Moleculin Biotech Inc — Quarterly Cash Flow (NASDAQ:MBRX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 16.93 M21.01 M21.59 M20.35 M22.13 M Total liabilities 10.95 M20.97 M28.76 M47.27 M7.12 M Total equity 5.98 M42 K-7.17 M-26.92 M15.01 M Total liabilities & shareholders' equities 16.93 M21.01 M21.59 M20.35 M22.13 M Total debt ————— Net debt —————

News

Moleculin Biotech releases CEO update on leukemia trial

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54%

Moleculin Biotech stock plunges after warrant exercise agreement

Moleculin Biotech raises $8.3 million through warrant exercise

Moleculin Biotech stock rises as AML drug trial shows promising results

Moleculin reports promising early data in pivotal AML treatment trial

Moleculin Biotech stock rises after securing key Japanese patent

Moleculin receives patent allowance in Japan for Annamycin preparation method

Moleculin launches CEO Corner to enhance investor communication

Moleculin Biotech stockholders approve warrant issuance, reject name change

Moleculin’s Annamycin shows no cardiotoxicity in cancer trials

Moleculin expects first MIRACLE trial data readout in Q1 2026